LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Jul 18, 2024
Finance
Venture Report: Five biotechs raise nearly $800M in two-day flurry
Plus: New capital for CytoReason, Truvian and Renalys
Read More
BioCentury
|
Nov 8, 2022
Distillery Therapeutics
Allosteric inhibitor of the KCNN4 channel for atrial fibrillation
Read More
BioCentury
|
Oct 27, 2021
Finance
Bain commits $300M to advance Cardurion’s CV programs
Bain Capital Life Sciences makes first big splash from new $1.9B third fund
Read More
BioCentury
|
Aug 27, 2021
Distillery Therapeutics
CaMKII gene therapy to preserve retinal ganglion cells
Read More
BioCentury
|
Aug 27, 2021
Distillery Therapeutics
Brain metabolite analog to treat ischemic stroke
Read More
BioCentury
|
Aug 27, 2020
Distillery Therapeutics
siRNAs against plaque-destabilizing molecule CAMK2G for atherosclerosis
DISEASE CATEGORY: Cardiovascular
INDICATION: Atherosclerosis Nanoparticles carrying siRNAs against CAMK2G, a plaque-destabilizing molecule expressed by macrophages, could treat atherosclerosis.
Read More
BioCentury
|
Jun 26, 2020
Distillery Therapeutics
FMR1 peptide therapy for Fragile X syndrome
Read More
BioCentury
|
Jun 18, 2019
Distillery Therapeutics
CAMKK2 identified as target for breast cancer
Read More
BioCentury
|
May 15, 2019
Translation in Brief
Lentiviral gene therapy could offer relief to refractory epilepsy patients
An epilepsy gene therapy from UCL could offer an alternative to brain surgery
Read More
BioCentury
|
May 6, 2019
Distillery Therapeutics
KCNA1 gene therapy for epilepsy
Read More
Items per page:
10
1 - 10 of 72